Chemomab Therapeutics Ltd.
$2.71
-0.01 (-0.37%)
Price as of Aug 28, 2026 market close
Performance
- 1 Month
- +77.1%
- 3 Months
- +35.5%
- YTD
- +64.2%
- 1 Year
- -22.1%
Price return, based on split- and dividend-adjusted closing prices.
Risk
- Volatility 1-year annualized
- 89.8%
- Largest decline max drawdown, since Aug 2025
- -63.8%
- Risk-adjusted return Sharpe ratio, 1-year
- 0.16
Own CMMB?
See how CMMB contributes to your portfolio's return, allocation, and risk.
7-day free trial, then $9/month.